Results 101 to 110 of about 12,501 (219)

Heavy Menstrual Bleeding: Experiences and Learnings From Patient Survey

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 3, June 2026.
ABSTRACT Background Heavy menstrual bleeding (HMB) affects 1 in 4 women. It is often debilitating for those experiencing it, resulting in negative impacts on quality of life. Prompted by a national call for better insights into the management of HMB, the authors sought to collect patient feedback regarding access to HMB treatment alongside satisfaction
Mikaela Jacka, Madeleine Ward, Katrina Guerin, Russell Dalton   +3 more
wiley   +1 more source

Emergency Contraception Counseling in California Community Pharmacies: A Mystery Caller Study

Pharmacy, 2019
This study was conducted to determine which emergency contraception (EC) methods are offered by community pharmacists in response to patient calls. Female mystery callers called all community pharmacies in two California cities using standardized scripts.
Lindsay Ditmars, Sally Rafie, Gellan Kashou, Kelly Cleland, Lisa Bayer, Tracey A. Wilkinson   +5 more
doaj   +1 more source

The Effectiveness of Non‐Steroidal Anti‐Inflammatory Drugs for Pain Relief During Outpatient Intrauterine Device Insertion: A Systematic Review and Meta‐Analysis

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 3, June 2026.
ABSTRACT Background Fear of procedural pain is a significant barrier to intrauterine device (IUD) uptake. Non‐steroidal anti‐inflammatory drugs (NSAIDs) are commonly used in IUD insertion for their analgesic and anti‐inflammatory properties; however, evidence for their effectiveness remains inconsistent.
Marita S. Bolic, Jack Ainsworth, Clare Heal, Natalie Drever   +3 more
wiley   +1 more source

Estetrol‐based combined oral contraceptives: A systematic review of clinical outcomes

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 983-998, June 2026.
This systematic review summarizes clinical outcomes of estetrol‐containing combined oral contraceptives, showing reliable contraceptive efficacy, predictable bleeding patterns, improved well‐being, and a favorable hemostatic and metabolic profile, suggesting a promising and potentially safer alternative to ethinylestradiol‐based formulations.
Mathilde Råberg, Ingeborg Rose Vad, Kara Hildur Axelsdóttir, Ellen Christine Leth Løkkegaard   +3 more
wiley   +1 more source

Emergency contraception today: discussion of experts and practice [PDF]

Гинекология, 2014
Emergency contraception with levonorgestrel for the practicing obstetricians-ginecologist is a well-known method of contraception. The modern science has analyzed the safety issues of its use, and recently has changed the understanding of the method ...
L V Erofeeva, V N Prilepskaya
doaj  

Fat reduction mediates the efficacy of intensive lifestyle interventions on fertility‐sparing treatment in overweight patients with endometrial cancer and intraepithelial neoplasia

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 1052-1063, June 2026.
Intensive lifestyle interventions‐based weight management targeting fat reduction may enhance fertility‐sparing treatment outcomes in overweight patients with endometrial cancer or its precursor. Our findings advocate the integration of body composition‐guided weight management into standardized protocols.
Sijia Liu, Li Li, Pengfei Wu, Lulu Wang, Qujia Gama, Manrong Wang, Jinyu Zhang, Liping Jin, Xuezhen Luo, Weiwei Shan, Bingyi Yang   +10 more
wiley   +1 more source

Availability of Oral Emergency Contraception in German Community Pharmacies—A Nationwide Cross‐Sectional Mystery Caller Study

Health Science Reports
Background and Aims In Germany, the “morning after pill” (oral emergency contraception [EC]), which contains the active ingredients ulipristal acetate (UPA) and levonorgestrel (LNG), can only be dispensed by community pharmacies (CPs).
Christian Kunow, Carolin Priepke, Bernhard Langer   +2 more
doaj   +1 more source

A Phase 1 Microtracer Study Evaluating the Mass Balance, Excretion, and Pharmacokinetics of Osivelotor in Healthy Participants

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Osivelotor (GBT021601) is an orally bioavailable, small molecule hemoglobin polymerization inhibitor in clinical development for the treatment of sickle cell disease (SCD). In this Phase 1 study, the disposition of osivelotor was assessed using accelerator mass spectrometry (AMS) after a single oral 200‐mg dose containing a microtracer amount ...
Eric I. Zimmerman, Ernesto Callegari, Raman Sharma, Adeyemi Adenola, Jessica Volpe, Karthik Seetharaman, Chenghong Zhang, Kenneth Duchin, Gregory S. Walker   +8 more
wiley   +1 more source

The Mirena(R) levonorgestrel system

, 2003
The levonorgestrel intrauterine system is a safe, efficacious, long-term contraceptive device. Additionally, it results in a decrease in the volume of menstrual blood loss in women with normal periods and those with menorrhagia.
McGavigan, C.J., Cameron, I.T.
core   +1 more source

Vascular health and exercise in females throughout the lifespan: Exploring puberty, pregnancy and menopause

Experimental Physiology, Volume 111, Issue 6, Page 2840-2859, 1 June 2026.
Abstract This narrative review highlights the impact of exercise on vascular health in females over the lifespan with an emphasis on puberty, pregnancy and menopause. These events encompass substantial changes in sex hormone levels, particularly oestrogens and progesterone.
Kathleen B. Miller, M. Erin Moir, Brandon G. Fico   +2 more
wiley   +1 more source